Journal of Veterinary Science

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

3D-culture models as drug-testing platforms in canine lymphoma and their cross talk with lymph node-derived stromal cells

  • An, Ju-Hyun (Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University) ;
  • Song, Woo-Jin (Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Jeju National University) ;
  • Li, Qiang (Department of Veterinary Medicine, College of Agriculture, Yanbian University) ;
  • Bhang, Dong-Ha (Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University) ;
  • Youn, Hwa-Young (Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University)
  • Received : 2020.10.14
  • Accepted : 2021.02.01
  • Published : 2021.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Malignant lymphoma is the most common hematopoietic malignancy in dogs, and relapse is frequently seen despite aggressive initial treatment. In order for the treatment of these recurrent lymphomas in dogs to be effective, it is important to choose a personalized and sensitive anticancer agent. To provide a reliable tool for drug development and for personalized cancer therapy, it is critical to maintain key characteristics of the original tumor. Objectives: In this study, we established a model of hybrid tumor/stromal spheroids and investigated the association between canine lymphoma cell line (GL-1) and canine lymph node (LN)-derived stromal cells (SCs). Methods: A hybrid spheroid model consisting of GL-1 cells and LN-derived SC was created using ultra low attachment plate. The relationship between SCs and tumor cells (TCs) was investigated using a coculture system. Results: TCs cocultured with SCs were found to have significantly upregulated multidrug resistance genes, such as P-qp, MRP1, and BCRP, compared with TC monocultures. Additionally, it was revealed that coculture with SCs reduced doxorubicin-induced apoptosis and G2/M cell cycle arrest of GL-1 cells. Conclusions: SCs upregulated multidrug resistance genes in TCs and influenced apoptosis and the cell cycle of TCs in the presence of anticancer drugs. This study revealed that understanding the interaction between the tumor microenvironment and TCs is essential in designing experimental approaches to personalized medicine and to predict the effect of drugs.

Keywords

Acknowledgement

This study was supported by the Research Institute for Veterinary Science, Seoul National University. In addition, this research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (550-20190038). These funds contributed to the collection, analysis, and interpretation of data in this study.

References

  1. Teske E. Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma. Vet Q. 1994;16(4):209-219. https://doi.org/10.1080/01652176.1994.9694451
  2. Uozurmi K, Nakaichi M, Yamamoto Y, Une S, Taura Y. Development of multidrug resistance in a canine lymphoma cell line. Res Vet Sci. 2005;78(3):217-224. https://doi.org/10.1016/j.rvsc.2004.09.012
  3. Flory AB, Rassnick KM, Erb HN, Garrett LD, Northrup NC, Selting KA, et al. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007). J Am Vet Med Assoc. 2011;238(4):501-506. https://doi.org/10.2460/javma.238.4.501
  4. Gavazza A, Lubas G, Valori E, Gugliucci B. Retrospective survey of malignant lymphoma cases in the dog: clinical, therapeutical and prognostic features. Vet Res Commun. 2008;32 Suppl 1:S291-S293.
  5. Niu B, Scott AD, Sengupta S, Bailey MH, Batra P, Ning J, et al. Protein-structure-guided discovery of functional mutations across 19 cancer types. Nat Genet. 2016;48(8):827-837. https://doi.org/10.1038/ng.3586
  6. Ahn DH, Ciombor KK, Mikhail S, Bekaii-Saab T. Genomic diversity of colorectal cancer: changing landscape and emerging targets. World J Gastroenterol. 2016;22(25):5668-5677. https://doi.org/10.3748/wjg.v22.i25.5668
  7. Breslin S, O'Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2013;18(5-6):240-249. https://doi.org/10.1016/j.drudis.2012.10.003
  8. Xu X, Farach-Carson MC, Jia X. Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnol Adv. 2014;32(7):1256-1268. https://doi.org/10.1016/j.biotechadv.2014.07.009
  9. Menshykau D. Emerging technologies for prediction of drug candidate efficacy in the preclinical pipeline. Drug Discov Today. 2017;22(11):1598-1603. https://doi.org/10.1016/j.drudis.2017.04.019
  10. Benien P, Swami A. 3D tumor models: history, advances and future perspectives. Future Oncol. 2014;10(7):1311-1327. https://doi.org/10.2217/fon.13.274
  11. Nath S, Devi GR. Three-dimensional culture systems in cancer research: focus on tumor spheroid model. Pharmacol Ther. 2016;163:94-108. https://doi.org/10.1016/j.pharmthera.2016.03.013
  12. Shoval H, Karsch-Bluman A, Brill-Karniely Y, Stern T, Zamir G, Hubert A, et al. Tumor cells and their crosstalk with endothelial cells in 3D spheroids. Sci Rep. 2017;7(1):10428. https://doi.org/10.1038/s41598-017-10699-y
  13. Langhans SA. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol. 2018;9:6. https://doi.org/10.3389/fphar.2018.00006
  14. DelNero P, Lane M, Verbridge SS, Kwee B, Kermani P, Hempstead B, et al. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways. Biomaterials. 2015;55:110-118. https://doi.org/10.1016/j.biomaterials.2015.03.035
  15. Li J, Wu X, Gong J, Yang J, Leng J, Chen Q, et al. Vascular endothelial growth factor induces multidrug resistance-associated protein 1 overexpression through phosphatidylinositol-3-kinase/protein kinase B signaling pathway and transcription factor specificity protein 1 in BGC823 cell line. Acta Biochim Biophys Sin (Shanghai). 2013;45(8):656-663. https://doi.org/10.1093/abbs/gmt062
  16. Di C, Zhao Y. Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review). Exp Ther Med. 2015;9(2):289-293. https://doi.org/10.3892/etm.2014.2141
  17. Correia AL, Bissell MJ. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat. 2012;15(1-2):39-49. https://doi.org/10.1016/j.drup.2012.01.006
  18. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309-322. https://doi.org/10.1016/j.ccr.2012.02.022
  19. Khodarev NN, Yu J, Labay E, Darga T, Brown CK, Mauceri HJ, et al. Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci. 2003;116(Pt 6):1013-1022. https://doi.org/10.1242/jcs.00281
  20. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 2003;3(11):867-878. https://doi.org/10.1038/nri1222
  21. Nakaichi M, Taura Y, Kanki M, Mamba K, Momoi Y, Tsujimoto H, et al. Establishment and characterization of a new canine B-cell leukemia cell line. J Vet Med Sci. 1996;58(5):469-471. https://doi.org/10.1292/jvms.58.469
  22. Gambara G, Gaebler M, Keilholz U, Regenbrecht CR, Silvestri A. From chemotherapy to combined targeted therapeutics: in vitro and in vivo models to decipher intra-tumor heterogeneity. Front Pharmacol. 2018;9:77. https://doi.org/10.3389/fphar.2018.00077
  23. Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC. Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. PLoS One. 2013;8(9):e75187. https://doi.org/10.1371/journal.pone.0075187
  24. Bahrami A, Hassanian SM, Khazaei M, Hasanzadeh M, Shahidsales S, Maftouh M, et al. The therapeutic potential of targeting tumor microenvironment in breast cancer: rational strategies and recent progress. J Cell Biochem. 2018;119(1):111-122. https://doi.org/10.1002/jcb.26183
  25. Nunes AS, Barros AS, Costa EC, Moreira AF, Correia IJ. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng. 2019;116(1):206-226. https://doi.org/10.1002/bit.26845
  26. Margolin DA, Silinsky J, Grimes C, Spencer N, Aycock M, Green H, et al. Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling. Neoplasia. 2011;13(9):874-886. https://doi.org/10.1593/neo.11324
  27. Severino P, Palomino DT, Alvarenga H, Almeida CB, Pasqualim DC, Cury A, et al. Human lymph node-derived fibroblastic and double-negative reticular cells alter their chemokines and cytokines expression profile following inflammatory stimuli. Front Immunol. 2017;8:141.
  28. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 1990;43(9):752-757. https://doi.org/10.1136/jcp.43.9.752
  29. Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett MS, Bates DO, et al. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol. 2006;168(3):1045-1053. https://doi.org/10.2353/ajpath.2006.050554
  30. Henke E, Nandigama R, Ergun S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci. 2020;6:160. https://doi.org/10.3389/fmolb.2019.00160
  31. Rohwer N, Cramer T. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat. 2011;14(3):191-201. https://doi.org/10.1016/j.drup.2011.03.001
  32. Nelson CM, Chen CS. VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension. J Cell Sci. 2003;116(Pt 17):3571-3581. https://doi.org/10.1242/jcs.00680
  33. Zandvliet M, Teske E, Schrickx JA. Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma. Toxicol In Vitro. 2014;28(8):1498-1506. https://doi.org/10.1016/j.tiv.2014.06.004
  34. Simon D, Moreno SN, Hirschberger J, Moritz A, Kohn B, Neumann S, et al. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma. J Am Vet Med Assoc. 2008;232(6):879-885. https://doi.org/10.2460/javma.232.6.879
  35. Pedersen SF, Hoffmann EK, Novak I. Cell volume regulation in epithelial physiology and cancer. Front Physiol. 2013;4:233. https://doi.org/10.3389/fphys.2013.00233
  36. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423-1437. https://doi.org/10.1038/nm.3394
  37. da Cunha BR, Domingos C, Stefanini AC, Henrique T, Polachini GM, Castelo-Branco P, et al. Cellular interactions in the tumor microenvironment: the role of secretome. J Cancer. 2019;10(19):4574-4587. https://doi.org/10.7150/jca.21780
  38. Yuan Y, Jiang YC, Sun CK, Chen QM. Role of the tumor microenvironment in tumor progression and the clinical applications (Review). Oncol Rep. 2016;35(5):2499-2515. https://doi.org/10.3892/or.2016.4660
  39. Deying W, Feng G, Shumei L, Hui Z, Ming L, Hongqing W. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells. Biosci Rep. 2017;37(2):37.
  40. Katsuno Y, Meyer DS, Zhang Z, Shokat KM, Akhurst RJ, Miyazono K, et al. Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition. Sci Signal. 2019;12(570):eaau8544. https://doi.org/10.1126/scisignal.aau8544
  41. Kim SM, Li Q, An JH, Chae HK, Yang JI, Ryu MO, et al. Enhanced angiogenic activity of dimethyloxalylglycine-treated canine adipose tissue-derived mesenchymal stem cells. J Vet Med Sci. 2019;81(11):1663-1670. https://doi.org/10.1292/jvms.19-0337
  42. Zandvliet M, Teske E, Schrickx JA, Mol JA. A longitudinal study of ABC transporter expression in canine multicentric lymphoma. Vet J. 2015;205(2):263-271. https://doi.org/10.1016/j.tvjl.2014.11.002